EPO and brain injury: Among the most promising pharmacological candidates in this regard was erythropoietin due to its neuroprotective properties as shown in experimental models of neonatal brain injury.9,10,11 Numerous clinical trials have investigated the effect of erythropoietin on neurodevelopmental outcome of children born very preterm.